Gluten-free diet in nonceliac disease

Nutrition in Clinical Practice

Volumn 26, Issue 3, 2011, Pages 294-299

  El Chammas, Khalil ^a   Danner, Elaine ^b  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Children's Hospital and Health Systems   (United States)

Author keywords

arthritis, rheumatoid; autistic disorder; celiac disease; cerebellar ataxia; dermatitis herpetiformis; diabetes mellitus; diet, gluten free; glutens; HIV enteropathy; irritable bowel syndrome

Indexed keywords

IMMUNOGLOBULIN A ANTIBODY; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

AUTISM; CELIAC DISEASE; CEREBELLAR ATAXIA; DERMATITIS HERPETIFORMIS; DIABETES MELLITUS; ENTEROPATHY; GLUTEN FREE DIET; HUMAN; IRRITABLE COLON; MULTIPLE SCLEROSIS; NEUROLOGIC DISEASE; NONHUMAN; PERIPHERAL NEUROPATHY; REVIEW; RHEUMATOID ARTHRITIS; STIFF MAN SYNDROME;

ARTHRITIS, RHEUMATOID; AUTISTIC DISORDER; CELIAC DISEASE; DERMATITIS HERPETIFORMIS; DIABETES MELLITUS; DIET, GLUTEN-FREE; HIV ENTEROPATHY; HUMANS; IRRITABLE BOWEL SYNDROME; NERVOUS SYSTEM DISEASES;

EID: 79957518383     PISSN: 08845336     EISSN: 19412452     Source Type: Journal    
DOI: 10.1177/0884533611405538     Document Type: Review

References (91)

1. Paveley WF. From Aretaeus to Crosby: a history of coeliac disease. BMJ. 1988 ; 297: 1646-1649 (Pubitemid 19020691)
2. Abrams JA, Brar P, Diamond B, Rotterdam H, Green PH. Utility in clinical practice of immunoglobulin a anti-tissue transglutaminase antibody for the diagnosis of celiac disease. Clin Gastroenterol Hepatol. 2006 ; 4: 726-730 (Pubitemid 43825803)
3. Rostom A, Dube C, Cranney A, et al. Celiac disease. Evid Rep Technol Assess (Summ). 2004 ; 104: 1-6
4. Grodzinsky E, Hed J, Skogh T. IgA antiendomysium antibodies have a high positive predictive value for celiac disease in asymptomatic patients. Allergy. 1994 ; 49: 593-597 (Pubitemid 24318461)
5. Ellis A, Linaker BD. Non-coeliac gluten sensitivity?. Lancet. 1978 ; 1: 1358-1359
6. Cooke WT, Smith WT. Neurological disorders associated with adult coeliac disease. Brain. 1966 ; 89: 683-722
7. Hadjivassiliou M, Chattopadhyay AK, Davies-Jones GA, Gibson A, Grunewald RA, Lobo AJ. Neuromuscular disorder as a presenting feature of coeliac disease. J Neurol Neurosurg Psychiatry. 1997 ; 63: 770-775 (Pubitemid 27520755)
8. Hadjivassiliou M, Gibson A, Davies-Jones GA, Lobo AJ, Stephenson TJ, Milford-Ward A. Does cryptic gluten sensitivity play a part in neurological illness?. Lancet. 1996 ; 347: 369-371 (Pubitemid 26046106)
9. Hadjivassiliou M, Grunewald RA, Chattopadhyay AK, et al. Clinical, radiological, neurophysiological, and neuropathological characteristics of gluten ataxia. Lancet. 1998 ; 352: 1582-1585 (Pubitemid 28515242)
10. Marsh MN. The natural history of gluten sensitivity: defining, refining and re-defining. QJM. 1995 ; 88: 9-13
11. Troncone R, Greco L, Mayer M, et al. In siblings of celiac children, rectal gluten challenge reveals gluten sensitization not restricted to celiac HLA. Gastroenterology. 1996 ; 111: 318-324 (Pubitemid 26256719)
12. Maurinõ ENS, Dezi R, Marraco G, et al. Evidence of gluten sensitivity in the rectal mucosa is becoming increasingly recognized as an important integrator of first-degree relatives of celiac disease patients. Gastroenterology. 1995 ; 108: A306
13. Bernini P, Bertini I, Calabro A, et al. Are patients with potential celiac disease really potential? The answer of metabonomics. J Proteome Res. 2011 ; 10: 714-721
14. Sardy M, Karpati S, Merkl B, Paulsson M, Smyth N. Epidermal transglutaminase (TGase 3) is the autoantigen of dermatitis herpetiformis. J Exp Med. 2002 ; 195: 747-757 (Pubitemid 34259719)
15. Reunala T, Kosnai I, Karpati S, Kuitunen P, Torok E, Savilahti E. Dermatitis herpetiformis: jejunal findings and skin response to gluten free diet. Arch Dis Child. 1984 ; 59: 517-522 (Pubitemid 14122080)
16. Collin P, Reunala T, Rasmussen M, et al. High incidence and prevalence of adult coeliac disease: augmented diagnostic approach. Scand J Gastroenterol. 1997 ; 32: 1129-1133 (Pubitemid 27523845)
17. Zone JJ. Skin manifestations of celiac disease. Gastroenterology. 2005 ; 128: S87 - S91
18. Garioch JJ, Lewis HM, Sargent SA, Leonard JN, Fry L. 25 years' experience of a gluten-free diet in the treatment of dermatitis herpetiformis. Br J Dermatol. 1994 ; 131: 541-545 (Pubitemid 24315424)
19. Frodin T, Gotthard R, Hed J, Molin L, Norrby K, Walan A. Gluten-free diet for dermatitis herpetiformis: the long-term effect on cutaneous, immunological and jejunal manifestations. Acta Derm Venereol. 1981 ; 61: 405-411 (Pubitemid 11015975)
20. Lewis HM, Renaula TL, Garioch JJ, et al. Protective effect of gluten-free diet against development of lymphoma in dermatitis herpetiformis. Br J Dermatol. 1996 ; 135: 363-367 (Pubitemid 26297828)
21. Longstreth GF, Thompson WG, Chey WD, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology. 2006 ; 130: 1480-1491
22. Boivin M. Socioeconomic impact of irritable bowel syndrome in Canada. Can J Gastroenterol. 2001 ; 15 (suppl B). 8B - 11B (Pubitemid 33740478)
23. Locke GR, Murray JA, Zinsmeister AR, Melton LJ, Talley NJ. Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clin Proc. 2004 ; 79: 476-482 (Pubitemid 38401767)
24. Hallert C, Granno C, Hulten S, et al. Living with coeliac disease: controlled study of the burden of illness. Scand J Gastroenterol. 2002 ; 37: 39-42 (Pubitemid 34074732)
25. Hallert C, Granno C, Grant C, et al. Quality of life of adult coeliac patients treated for 10 years. Scand J Gastroenterol. 1998 ; 33: 933-938 (Pubitemid 28439309)
26. Ford AC, Chey WD, Talley NJ, Malhotra A, Spiegel BM, Moayyedi P. Yield of diagnostic tests for celiac disease in individuals with symptoms suggestive of irritable bowel syndrome: systematic review and meta-analysis. Arch Intern Med. 2009 ; 169: 651-658
27. Drossman DA. Review article: an integrated approach to the irritable bowel syndrome. Aliment Pharmacol Ther. 1999 ; 13 (suppl 2). 3-14 (Pubitemid 29219276)
28. Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study. BMJ. 1999 ; 318: 565-566 (Pubitemid 29188957)
29. Spiller RC, Jenkins D, Thornley JP, et al. Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome. Gut. 2000 ; 47: 804-811
30. Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal survey of patients. BMJ. 1997 ; 314: 779-782 (Pubitemid 27117047)
31. Gwee KA, Collins SM, Read NW, et al. Increased rectal mucosal expression of interleukin 1beta in recently acquired post-infectious irritable bowel syndrome. Gut. 2003 ; 52: 523-526 (Pubitemid 36363405)
32. Marshall JK, Thabane M, Garg AX, Clark WF, Salvadori M, Collins SM. Incidence and epidemiology of irritable bowel syndrome after a large waterborne outbreak of bacterial dysentery. Gastroenterology. 2006 ; 131: 445-450 (Pubitemid 44142459)
33. Pimentel M, Chow EJ, Lin HC. Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome. a double-blind, randomized, placebo-controlled study. Am J Gastroenterol. 2003 ; 98: 412-419 (Pubitemid 36232393)
34. Ragnarsson G, Bodemar G. Pain is temporally related to eating but not to defaecation in the irritable bowel syndrome (IBS): patients' description of diarrhea, constipation and symptom variation during a prospective 6-week study. Eur J Gastroenterol Hepatol. 1998 ; 10: 415-421 (Pubitemid 28241429)
35. Fernandez-Banares F, Esteve-Pardo M, de Leon R, et al. Sugar malabsorption in functional bowel disease: clinical implications. Am J Gastroenterol. 1993 ; 88: 2044-2050 (Pubitemid 23352169)
36. Atkinson W, Sheldon TA, Shaath N, Whorwell PJ. Food elimination based on IgG antibodies in irritable bowel syndrome: a randomised controlled trial. Gut. 2004 ; 53: 1459-1464 (Pubitemid 39265266)
37. Zar S, Kumar D, Benson MJ. Food hypersensitivity and irritable bowel syndrome. Aliment Pharmacol Ther. 2001 ; 15: 439-449 (Pubitemid 32242770)
38. Zar S, Benson MJ, Kumar D. Food-specific serum IgG4 and IgE titers to common food antigens in irritable bowel syndrome. Am J Gastroenterol. 2005 ; 100: 1550-1557 (Pubitemid 41032362)
39. Galligan JJ. Ligand-gated ion channels in the enteric nervous system. Neurogastroenterol Motil. 2002 ; 14: 611-623 (Pubitemid 35472013)
40. Cameron HL, Perdue MH. Muscarinic acetylcholine receptor activation increases transcellular transport of macromolecules across mouse and human intestinal epithelium in vitro. Neurogastroenterol Motil. 2007 ; 19: 47-56 (Pubitemid 44952778)
41. Cummins AG, Thompson FM, Butler RN, et al. Improvement in intestinal permeability precedes morphometric recovery of the small intestine in coeliac disease. Clin Sci (Lond). 2001 ; 100: 379-386 (Pubitemid 32324335)
42. Fasano A, Not T, Wang W, et al. Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet. 2000 ; 355: 1518-1519 (Pubitemid 30237361)
43. Verdu EF, Huang X, Natividad J, et al. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. Am J Physiol Gastrointest Liver Physiol. 2008 ; 294: G217 - G225
44. Natividad J, Jury J, Sanz Y, et al. Role of intestinal barrier modulation by nonsteroidal anti-inflammatory drugs in gluten-induced epithelial damage in HLA-DQ8/HCD4 transgenic mice. Gastroenterology. 2008 ; 134: A - 151
45. Pinier M, Verdu EF, Nasser-Eddine M, et al. Polymeric binders suppress gliadin-induced toxicity in the intestinal epithelium. Gastroenterology. 2009 ; 136: 288-298
46. Verdu EF, Armstrong D, Murray JA. Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am J Gastroenterol. 2009 ; 104: 1587-1594
47. Holmes G Epilepsy and Other Neurological Disorders in Coeliac Disease. Gobbi G AF Naccarato S Banchini G, ed. London, UK: John Libbey ; 1997: 251-264.
48. Briani C, Zara G, Alaedini A, et al. Neurological complications of celiac disease and autoimmune mechanisms: a prospective study. J Neuroimmunol. 2008 ; 195: 171-175
49. Hadjivassiliou M, Sanders DS, Grunewald RA, Woodroofe N, Boscolo S, Aeschlimann D. Gluten sensitivity: from gut to brain. Lancet Neurol. 2010 ; 9: 318-330
50. Hadjivassiliou M Ataxia Disorders: Handbook of Clinical Neurology Series. Subramony SH Durr A, ed. Elsevier ;
51. Brucke T, Kollegger H, Schmidbauer M, Muller C, Podreka I, Deecke L. Adult coeliac disease and brainstem encephalitis. J Neurol Neurosurg Psychiatry. 1988 ; 51: 456-457 (Pubitemid 18097596)
52. Deconinck N, Scaillon M, Segers V, Groswasser JJ, Dan B. Opsoclonus-myoclonus associated with celiac disease. Pediatr Neurol. 2006 ; 34: 312-314
53. Pereira AC, Edwards MJ, Buttery PC, et al. Choreic syndrome and coeliac disease: a hitherto unrecognised association. Mov Disord. 2004 ; 19: 478-482 (Pubitemid 38559655)
54. Hadjivassiliou M, Sanders DS, Woodroofe N, Williamson C, Grunewald RA. Gluten ataxia. Cerebellum. 2008 ; 7: 494-498
55. Kaukinen K, Collin P, Laurila K, Kaartinen T, Partanen J, Maki M. Resurrection of gliadin antibodies in coeliac disease: deamidated gliadin peptide antibody test provides additional diagnostic benefit. Scand J Gastroenterol. 2007 ; 42: 1428-1433 (Pubitemid 350125555)
56. Hadjivassiliou M, Davies-Jones GA, Sanders DS, Grunewald RA. Dietary treatment of gluten ataxia. J Neurol Neurosurg Psychiatry. 2003 ; 74: 1221-1224
57. Wilkinson ID, Hadjivassiliou M, Dickson JM, et al. Cerebellar abnormalities on proton MR spectroscopy in gluten ataxia. J Neurol Neurosurg Psychiatry. 2005 ; 76: 1011-1013 (Pubitemid 40909566)
58. Luostarinen L, Himanen SL, Luostarinen M, Collin P, Pirttila T. Neuromuscular and sensory disturbances in patients with well treated coeliac disease. J Neurol Neurosurg Psychiatry. 2003 ; 74: 490-494 (Pubitemid 36379373)
59. Chin RL, Sander HW, Brannagan TH, et al. Celiac neuropathy. Neurology. 2003 ; 60: 1581-1585 (Pubitemid 36618081)
60. Hadjivassiliou M, Kandler RH, Chattopadhyay AK, et al. Dietary treatment of gluten neuropathy. Muscle Nerve. 2006 ; 34: 762-766 (Pubitemid 44877560)
61. Hadjivassiliou M, Grunewald RA, Lawden M, Davies-Jones GA, Powell T, Smith CM. Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology. 2001 ; 56: 385-388 (Pubitemid 32144152)
62. Hadjivassiliou MWC, Grunewald RA, et al. Glutamic acid decarboxylase as a target antigen in gluten sensitivity: the link to neurological manifestations?. J Neurol Neurosurg Psychiatry. 2005 ; 76: 150-158
63. MacDougall R. No bed of roses. World Med. 1973 ; 8: 98-99
64. Matheson NA. Multiple sclerosis and diet [letter]. Lancet. 1974 ; 2: 831
65. Borhani Haghighi A, Ansari N, Mokhtari M, Geramizadeh B, Lankarani KB. Multiple sclerosis and gluten sensitivity. Clin Neurol Neurosurg. 2007 ; 109: 651-653 (Pubitemid 47248027)
66. Hadjivassiliou M, Sanders DS, Grunewald RA. Multiple sclerosis and occult gluten sensitivity. Neurology. 2005 ; 64: 933-934 (Pubitemid 40316355)
67. Tolcher AW, Gerson SL, Denis L, et al. Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules. Br J Cancer. 2003 ; 88: 1004-1011 (Pubitemid 36560766)
68. Pengiran Tengah CD, Lock RJ, Unsworth DJ, Wills AJ. Multiple sclerosis and occult gluten sensitivity. Neurology. 2004 ; 62: 2326-2327 (Pubitemid 38787802)
69. Frostegard J. Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol. 2005 ; 25: 1776-17785
70. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003 ; 107: 1303-1307 (Pubitemid 36314415)
71. Wolfe F, Freundlich B, Straus WL. Increase in cardiovascular and cerebrovascular disease prevalence in rheumatoid arthritis. J Rheumatol. 2003 ; 30: 36-40 (Pubitemid 36077769)
72. Park YB, Ahn CW, Choi HK, et al. Atherosclerosis in rheumatoid arthritis: morphologic evidence obtained by carotid ultrasound. Arthritis and Rheumatism. 2002 ; 46: 1714-1719 (Pubitemid 34774501)
73. Rantapaa-Dahlqvist S, Neumann-Andersen G, Backman C, Dahlen G, Stegmayr B. Echocardiographic findings, lipids and lipoprotein(a) in patients with systemic lupus erythematosus. Clin Rheumatol. 1997 ; 16: 140-148 (Pubitemid 27119785)
74. Situnayake RD, Kitas G. Dyslipidemia and rheumatoid arthritis. Ann Rheum Dis. 1997 ; 56: 341-342
75. Su J, Georgiades A, Wu R, Thulin T, de Faire U, Frostegard J. Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension. Atherosclerosis. 2006 ; 188: 160-166 (Pubitemid 44160704)
76. Faria-Neto JR, Chyu KY, Li X, et al. Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice. Atherosclerosis. 2006 ; 189: 83-90 (Pubitemid 44468069)
77. Elkan AC, Sjoberg B, Kolsrud B, Ringertz B, Hafstrom I, Frostegard J. Gluten-free vegan diet induces decreased LDL and oxidized LDL levels and raised atheroprotective natural antibodies against phosphorylcholine in patients with rheumatoid arthritis: a randomized study. Arthritis Res Ther. 2008 ; 10: R34
78. Hafstrom I, Ringertz B, Spangberg A, et al. A vegan diet free of gluten improves the signs and symptoms of rheumatoid arthritis: the effects on arthritis correlate with a reduction in antibodies to food antigens. Rheumatology (Oxford). 2001 ; 40: 1175-1179
79. Dabelea D, Bell RA, D'Agostino RB, et al. Incidence of diabetes in youth in the United States. JAMA. 2007 ; 297: 2716-2724 (Pubitemid 47001097)
80. Narula P, Porter L, Langton J, et al. Gastrointestinal symptoms in children with type 1 diabetes screened for celiac disease. Pediatrics. 2009 ; 124: e489 - e495
81. Bosi E, Pastore MR, Molteni L, Bazzigaluppi E, Bonifacio E, Piemonti L. Gluten-free diet in subjects at risk for type 1 diabetes: a tool for delaying progression to clinical disease?. Adv Exp Med Biol. 2005 ; 569: 157-158 (Pubitemid 43779620)
82. Ullrich R, Zeitz M, Heise W, L'Age M, Hoffken G, Riecken EO. Small intestinal structure and function in patients infected with human immunodeficiency virus (HIV): evidence for HIV-induced enteropathy. Ann Intern Med. 1989 ; 111: 15-21 (Pubitemid 19167592)
83. Quinones A, Lifshitz A, Aguirre Garcia J, Halabe Cherem J, Laredo F, Vazquez-Saavedra JA. Treatment of enteropathy in AIDS with a gluten-free diet: preliminary communication. Rev Invest Clin. 1989 ; 41: 223-226
84. Nellen H, Flores G, Wacher N. Treatment of human immunodeficiency virus enteropathy with a gluten-free diet. Arch Intern Med. 2000 ; 160: 244 (Pubitemid 30054349)
85. Elder JH, Shankar M, Shuster J, Theriaque D, Burns S, Sherrill L. The gluten-free, casein-free diet in autism: results of a preliminary double blind clinical trial. J Autism Dev Disord. 2006 ; 36: 413-420 (Pubitemid 43828665)
86. Millward C, Ferriter M, Calver S, Connell-Jones G. Gluten- and casein-free diets for autistic spectrum disorder. Cochrane Database Syst Rev. 2008 ; ( 2 ):
87. Rose C, Armbruster FP, Ruppert J, Igl BW, Zillikens D, Shimanovich I. Autoantibodies against epidermal transglutaminase are a sensitive diagnostic marker in patients with dermatitis herpetiformis on a normal or gluten-free diet. J Am Acad Dermatol. 2009 ; 61: 39-43
88. Wahnschaffe U, Ullrich R, Riecken EO, Schulzke JD. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology. 2001 ; 121: 1329-1338 (Pubitemid 33140450)
89. Shor DB, Barzilai O, Ram M, et al. Gluten sensitivity in multiple sclerosis: experimental myth or clinical truth?. Ann N Y Acad Sci. 2009 ; 1173: 343-349
90. Koehne Vde B, Bahia M, Lanna CC, Pinto MR, Bambirra EA, Cunha AS. Prevalence of serological markers for celiac disease (IgA and IgG class antigliadin antibodies and IgA class antiendomysium antibodies) in patients with autoimmune rheumatologic diseases in Belo Horizonte, MG, Brazil. Arq Gastroenterol. 2010 ; 47: 250-256
91. Kakleas K, Karayianni C, Critselis E, et al. The prevalence and risk factors for coeliac disease among children and adolescents with type 1 diabetes mellitus. Diabetes Res Clin Pract. 2010 ; 90: 202-208